Texas Oncology-Austin Center

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Endometrial cancer1 trial
• Ovarian cancer1 trial

Phase

• Phase 22 trials

Status

• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Incyte Corporation2 trials

Running trials

• Recruiting

  A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  NCT07023627· Phase 2· Incyte Corporation· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ovarian cancer1 recruiting

Closed trials

• Completed

  Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.

  NCT04463771· Phase 2· Incyte Corporation· Source